share_log

Cantor Fitzgerald Reiterates Overweight on Alpha Tau Medical, Maintains $23 Price Target

Benzinga ·  Aug 29, 2023 10:24

Cantor Fitzgerald analyst Kristen Kluska reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and maintains $23 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment